Summary & Overview
HCPCS J2001: Lidocaine HCl Injection for Intravenous Infusion, 10 mg
HCPCS Level II code J2001 denotes a 10 mg unit of lidocaine hydrochloride administered via intravenous infusion. This injectable medication code identifies discrete drug billing for intravenous local anesthetic used in procedural, analgesic, or infusion contexts. Nationally, accurate coding for injectable medications like lidocaine matters for appropriate drug cost capture, clinical documentation, and claims processing across hospital and ambulatory settings.
Key payers in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical role and service settings, plus what to expect in payer coverage considerations and common billing modifiers (listed elsewhere). The publication outlines typical use cases for infusion-capable settings and highlights where further policy or reimbursement details can affect claim adjudication.
This summary provides a national-level context rather than state-specific guidance. It is intended to orient clinicians, billing staff, and policy analysts to the core meaning of J2001, the likely service environments, and the payer landscape relevant to medication administration claims. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J2001 represents an injection of lidocaine hydrochloride for intravenous infusion, 10 mg. This service is typically classified as a medication administration for procedural or analgesic use where intravenous local anesthetic is required.
Service Type: Intravenous medication administration
Typical Site of Service: Hospital inpatient, hospital outpatient, ambulatory surgery center, or other infusion-capable settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult inpatient or outpatient scheduled to receive intravenous lidocaine for analgesia, antiarrhythmic effect, or perioperative pain management. Example: a 58-year-old male recovering from abdominal surgery develops acute postoperative neuropathic pain poorly controlled with opioids; the anesthesia team initiates an IV lidocaine infusion after a bolus documented as J2001 (injection, lidocaine HCl for intravenous infusion, 10 mg units), with continuous monitoring in a post-anesthesia care unit or surgical ward. The clinical workflow includes verification of indication and allergies, baseline vitals and cardiac monitoring, calculation of dose based on weight and comorbidities, preparation of the medication by pharmacy or nursing, administration of the specified 10 mg unit vial(s) and titration per protocol, documentation of infusion start/stop times, patient response, and any adverse events. Typical sites of service are the hospital inpatient ward, post-anesthesia care unit, ambulatory surgery center, or an infusion center when used for chronic pain protocols. Billing uses J2001 for the injectable lidocaine supplied for IV infusion; associated billing may include service, monitoring, and facility codes as appropriate.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Primary procedure |